27 Jul

Howard Marks on FANG Stocks: ‘It Could Produce More Pain’

WRITTEN BY Sarah Sands

Howard Marks on FANG stocks

Billionaire investor and co-founder of Oaktree Capital Management Howard Marks shared his latest views on FANG stocks, ETFs, and Bitcoin at the Delivering Alpha Conference on July 23.

Howard Marks on FANG Stocks: ‘It Could Produce More Pain’

Marks expressed his concern about high-growth technology stocks. He believes FANG stocks—Facebook (FB), Amazon (AMZN), Netflix (NFLX), and Alphabet (GOOGL)—could mean more pain for investors since many ETFs have invested heavily in them, and these ETFs only focus on the “momentum” factor. According to Marks, ETFs’ continuous inflow into FANG stocks and the gradual new highs in these stocks make them riskier.

Marks said, “Yes. They are great companies, but ETFs may have accentuated the flow of capital into those stocks. Things that are most hyped … produce the most pain. A conspicuous number of ETFs are concentrated in the same stocks. When things go cold … who is going to buy it?” In the present investment world, ETFs are performing like “perpetual motion machines.” Their momentum strategy could be a major risk for the funds themselves as well as stocks.

FANG performance

FANG stocks have put on a great performance so far in this year and in the last nine years’ bull market. Facebook, Amazon, Netflix, and Alphabet gained 23.25%, 59.3%, 89%, and 21.1%, respectively, on a year-to-date basis as of July 25.

In the next part of this series, we’ll see why Facebook recorded it biggest decline on July 26.

Latest articles

Tesla (TSLA) stock short sellers seem to be getting exasperated. Notably, Tesla stock has been the short sellers’ favorite.

In the week that ended on November 15, natural gas prices fell 3.5% and settled at 2.688 per MMBtu (million British thermal units).

The Dow Jones Index (DIA) and S&P 500 (SPY) are trading at record highs and on Friday the Dow Jones crossed the 28,000 level for the first time.

Goldman Sachs (GS) settled a lawsuit that alleged it rigged bond prices. Also, Deutsche Bank agreed to pay a fine of $15 million to settle a lawsuit.

In the November 15 premarket trading session, Amarin Corporation (AMRN) stock rose more than 7%, caused by the FDA positive decision for Vascepa.

In the November 14 trading session, Aurora Cannabis (ACB) stock fell 12.7% from the previous session during after-hours trading.